U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry EPIMERIC
Molecular Formula C29H34O6
Molecular Weight 478.5767
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TRIBENOSIDE

SMILES

[H][C@@]1(OC(OCC)[C@H](O)[C@H]1OCC2=CC=CC=C2)[C@@H](COCC3=CC=CC=C3)OCC4=CC=CC=C4

InChI

InChIKey=ULLNJSBQMBKOJH-VIVFLBMVSA-N
InChI=1S/C29H34O6/c1-2-32-29-26(30)28(34-20-24-16-10-5-11-17-24)27(35-29)25(33-19-23-14-8-4-9-15-23)21-31-18-22-12-6-3-7-13-22/h3-17,25-30H,2,18-21H2,1H3/t25-,26-,27-,28-,29?/m1/s1

HIDE SMILES / InChI

Description

Tribenoside, a glucofuranoside derivative has been shown to have potent anti-allergic and anti-inflammatory properties. It has been reported to display a pluripotent antagonistic action against histamine, serotonin, bradykinin and other inflammatory substances. Tribenoside decrease capillary permeability, thus reducing edema. Tribenoside combat the pathological processes of capillaries and veins. It is used in adults and adolescents for treatment of venous circulation diseases. Although Tribenoside is derived from a sugar substance, it doesn’t affect the carbohydrate metabolism even in diabetics. Tribenoside might cause some side effects such as skin redness, headache. Very rare cases are: systemic anaphylaxis, including urticaria, angioedema.

Originator

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Glyvenol
Secondary
Glyvenol
Palliative
Glyvenol

PubMed

Sample Use Guides

In Vivo Use Guide
Recommended dosage is of 1 dragee, 3 to 4 times a day (during or after meals). The daily dose (800 mg) should not be exceeded.
Route of Administration: Oral
In Vitro Use Guide
The expression of laminin alpha5 in the tribenoside-treated (at concentration 30uM) HaCaT cells was four times higher than that of control cells.